Label‐Free Cell Migration Assay Using Magnetic Exclusion
Source abstract
Abstract
Abstract In vitro wound healing assays are widely used to investigate cell migration during various physiologic and pathologic processes. However, traditional scratch‐based assays produce cell‐free areas that are not reproducible, whereas the alternate insert‐based exclusion method is expensive and time‐consuming. Here, a rapid, label‐free, insert‐free magnetic exclusion technique, where magnetic fields are used to create cell‐free areas is described. Suspensions of diamagnetic cells in a paramagnetic culture medium are seeded into microwells placed on an array of the coaxially arranged ring and cylinder magnets. In the presence of an inhomogeneous field, the magnetic susceptibility difference drives the cells toward an annular region of the lowest field strength. Annular cell aggregates of reproducible dimensions are produced on tissue culture‐treated and collagen I‐fibronectin coated surfaces within 3 h. The effects of the paramagnetic agent on cell viability, metabolism, and gene expression are investigated. A mathematical model reveals the dynamics of the cell‐free area closure. The magnetic exclusion technique is inexpensive, easy to use, and amenable to automation. Potential applications include cancer research, high throughput drug discovery, and screening.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Cellular Mechanics and Interactions · Cancer Cells and Metastasis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Biomedical Engineering McMaster University Hamilton ON L8S 4L7 Canada
Department of Mechanical Engineering McMaster University Hamilton ON L8S 4L7 Canada
Firestone Institute for Respiratory Health – Division of Respirology Department of Medicine McMaster University Hamilton ON L8N 4A6 Canada
Department of Materials Science and Engineering McMaster University Hamilton ON L8S 4L7 Canada
Funding
Natural Sciences and Engineering Research Council of Canada
References (59)
Show source-provided references
1. Trepat X. · 2012 · 100
2. 10.1038/s41584-018-0151-010.1038/s41584-018-0151-0 ↗
3. 10.1101/cshperspect.a00595910.1101/cshperspect.a005959 ↗
4. 10.1242/jcs.0266210.1242/jcs.02662 ↗
5. 10.1038/nri.2016.4910.1038/nri.2016.49 ↗
6. 10.1186/1472-6750-4-2110.1186/1472-6750-4-21 ↗
7. 10.1016/S0960-9822(00)00579-010.1016/S0960-9822(00)00579-0 ↗
8. 10.1016/S0092-8674(01)00471-810.1016/S0092-8674(01)00471-8 ↗
9. 10.1242/jcs.0028810.1242/jcs.00288 ↗
10. 10.3390/pharmaceutics301010710.3390/pharmaceutics3010107 ↗
11. 10.1038/nprot.2007.3010.1038/nprot.2007.30 ↗
12. 10.1016/j.mrrev.2012.08.00110.1016/j.mrrev.2012.08.001 ↗
13. 10.1177/221106821142655010.1177/2211068211426550 ↗
14. 10.1073/pnas.030758810010.1073/pnas.0307588100 ↗
15. 10.1073/pnas.070506210410.1073/pnas.0705062104 ↗
16. 10.4161/cam.3622410.4161/cam.36224 ↗
17. 10.1177/108705711039334010.1177/1087057110393340 ↗
18. 10.1038/srep0300010.1038/srep03000 ↗
19. 10.1038/nnano.2010.2310.1038/nnano.2010.23 ↗
20. 10.3390/ijms16102441710.3390/ijms161024417 ↗
21. 10.1063/1.358188310.1063/1.3581883 ↗
22. 10.1038/s41598-018-25718-910.1038/s41598-018-25718-9 ↗
23. 10.1021/acsbiomaterials.6b0061410.1021/acsbiomaterials.6b00614 ↗
24. 10.34133/2019/985459310.34133/2019/9854593 ↗
25. 10.1002/adma.20170503410.1002/adma.201705034 ↗
26. 10.1021/acsbiomaterials.0c0023310.1021/acsbiomaterials.0c00233 ↗
27. 10.1016/j.ces.2008.10.00810.1016/j.ces.2008.10.008 ↗
28. 10.1016/j.jtbi.2015.10.04010.1016/j.jtbi.2015.10.040 ↗
29. 10.1096/fj.201901063RR10.1096/fj.201901063RR ↗
30. 10.3390/ijms1804068310.3390/ijms18040683 ↗
31. 10.1183/09031936.0001981010.1183/09031936.00019810 ↗
32. 10.1073/pnas.090056110610.1073/pnas.0900561106 ↗
33. 10.1039/C7BM01050H10.1039/C7BM01050H ↗
34. 10.1063/1.505223910.1063/1.5052239 ↗
35. 10.3389/fonc.2018.0014510.3389/fonc.2018.00145 ↗
36. 10.1089/wound.2013.048510.1089/wound.2013.0485 ↗
37. 10.1164/rccm.201204-0754OC10.1164/rccm.201204-0754OC ↗
38. 10.1186/s12931-017-0680-010.1186/s12931-017-0680-0 ↗
39. 10.1111/j.1432-0436.2006.00069.x10.1111/j.1432-0436.2006.00069.x ↗
40. 10.1016/j.addr.2020.09.00510.1016/j.addr.2020.09.005 ↗
41. 10.18632/oncotarget.1996910.18632/oncotarget.19969 ↗
42. 10.33176/AACB-19-0002410.33176/AACB-19-00024 ↗
43. 10.3390/molecules1403126310.3390/molecules14031263 ↗
44. Jafari M. · Cell J. · 2019 · 20 · 604
45. 10.1016/j.ygeno.2017.08.00710.1016/j.ygeno.2017.08.007 ↗
46. 10.1016/S1479-666X(08)80114-X10.1016/S1479-666X(08)80114-X ↗
47. 10.1089/wound.2011.032610.1089/wound.2011.0326 ↗
48. 10.1096/fasebj.14.10.136210.1096/fasebj.14.10.1362 ↗
49. 10.1165/ajrcmb.18.1.274010.1165/ajrcmb.18.1.2740 ↗
50. 10.1101/cshperspect.a00507410.1101/cshperspect.a005074 ↗
51. 10.1038/385537a010.1038/385537a0 ↗
52. 10.1007/s11538-019-00589-x10.1007/s11538-019-00589-x ↗
53. 10.1089/10763270432306183410.1089/107632704323061834 ↗
54. 10.1016/j.physd.2019.06.00510.1016/j.physd.2019.06.005 ↗
55. 10.1371/journal.pcbi.100846210.1371/journal.pcbi.1008462 ↗
56. 10.3233/ISB-18047010.3233/ISB-180470 ↗
57. 10.1016/j.ces.2018.01.00410.1016/j.ces.2018.01.004 ↗
58. 10.1109/4235.99601710.1109/4235.996017 ↗
59. 10.1093/nar/gng01510.1093/nar/gng015 ↗